MDEV Fact Sheet: First Trust Indxx Medical Devices ETF
Share
$21.84
close, Nov 20, 2026
Over the year to Nov 19, 2026, MDEV returned +8.9% in total and charged 0.70% a year.
- 1-year total return
- +7.6%
- to Nov 20, 2026
- Expense ratio
- 0.70%
- a year
- Net assets
- $3.3m
- on Nov 19, 2026
- Net flow, last 5 trading days
- $0
- daily basis to Nov 19, 2026
Growth of $10,000, 1 year
MDEV $10,894 +8.9% · URTH $10,928 +9.3% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.
Returns
WindowTotal return
1 month+0.8%
3 months+0.8%
Year to date+4.2%
1 year+7.6%
3 years+19.2%
5 years−16.8%
Total return, distributions reinvested, each window to Nov 20, 2026.
Ten largest positions
HoldingWeight
Teleflex Incorporated2.49%
GE HealthCare Technologies Inc.2.38%
Edwards Lifesciences Corporation2.33%
LivaNova Plc2.30%
Koninklijke Philips N.V.2.29%
Steris Plc2.27%
Straumann Holding AG (Registered)2.26%
Alcon Inc.2.24%
Becton, Dickinson and Company2.21%
Zimmer Biomet Holdings, Inc.2.18%
MDEV top ten by weight, 22.9% of the fund, of its 50 equity positions, from the holdings published by its issuer for Nov 19, 2026.
Facts
Holds 50 stocks in therapeutics and medical devices, 47% of its weight in S&P 500 companies · First traded Jun 23, 2021 · Benchmark Its own holdings, as of Nov 19, 2026